BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Filippatos G, Farmakis D, Parissis J. Renal dysfunction and heart failure: things are seldom what they seem. European Heart Journal 2014;35:416-8. [DOI: 10.1093/eurheartj/eht515] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Parissis JT, Farmakis D, Andreoli C, Rafouli-stergiou P, Ambrosio G, Anastasiou-nana M, Filippatos G. Cardio–reno–hepatic interactions in acute heart failure: The role of γ-glutamyl transferase. International Journal of Cardiology 2014;173:556-7. [DOI: 10.1016/j.ijcard.2014.03.127] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
2 Pérez Calvo J, Josa Laorden C, Giménez López I. Renal function assessment in heart failure. Revista Clínica Española (English Edition) 2017;217:267-88. [DOI: 10.1016/j.rceng.2017.03.003] [Reference Citation Analysis]
3 Tereshchenko SN, Zhirov IV, Uskach TM, Saidova MA, Golitsyn SP, Gupalo EM, Nasonova SN, Narusov OY, Safiullina AA, Tereshchenko AS, Stukalova OV. EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020). Evrazijskij kardiologičeskij žurnal 2020. [DOI: 10.38109/2225-1685-2020-3-6-76] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rafouli-Stergiou P, Parissis JT, Farmakis D, Bistola V, Frogoudaki A, Vasiliadis K, Ikonomidis I, Paraskevaidis I, Kremastinos D, Filippatos G, Lekakis J. Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment. J Cardiovasc Med (Hagerstown) 2017;18:771-3. [PMID: 25643197 DOI: 10.2459/JCM.0000000000000244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
5 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129-2200. [PMID: 27206819 DOI: 10.1093/eurheartj/ehw128] [Cited by in Crossref: 8146] [Cited by in F6Publishing: 6589] [Article Influence: 1357.7] [Reference Citation Analysis]
6 Farmakis D, Chrysohoou C, Giamouzis G, Giannakoulas G, Hamilos M, Naka K, Tzeis S, Xydonas S, Karavidas A, Parissis J. The management of atrial fibrillation in heart failure: an expert panel consensus. Heart Fail Rev 2020. [PMID: 32468277 DOI: 10.1007/s10741-020-09978-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jung S, Bosch A, Kolwelter J, Striepe K, Kannenkeril D, Schuster T, Ott C, Achenbach S, Schmieder RE. Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction. ESC Heart Fail 2021;8:1562-70. [PMID: 33559346 DOI: 10.1002/ehf2.13257] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Casado Cerrada J, Zabaleta Camino J, Fontecha Ortega M. Target organ damage in acute heart failure. Revista Clínica Española (English Edition) 2016;216:99-105. [DOI: 10.1016/j.rceng.2015.10.003] [Reference Citation Analysis]
9 Russian Society of Cardiology (RSC) (. 2020 Clinical practice guidelines for Chronic heart failure. Russ J Cardiol 2020;25:4083. [DOI: 10.15829/1560-4071-2020-4083] [Cited by in Crossref: 63] [Cited by in F6Publishing: 13] [Article Influence: 31.5] [Reference Citation Analysis]
10 Reid R, Ezekowitz JA, Brown PM, McAlister FA, Rowe BH, Braam B. The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function. PLoS One 2015;10:e0138579. [PMID: 26380982 DOI: 10.1371/journal.pone.0138579] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
11 Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol 2016;12:610-23. [DOI: 10.1038/nrneph.2016.113] [Cited by in Crossref: 171] [Cited by in F6Publishing: 148] [Article Influence: 28.5] [Reference Citation Analysis]
12 Boriani G, Savelieva I, Dan GA, Deharo JC, Ferro C, Israel CW, Lane DA, La Manna G, Morton J, Mitjans AM, Vos MA, Turakhia MP, Lip GY; Document reviewers. Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2015;17:1169-96. [PMID: 26108808 DOI: 10.1093/europace/euv202] [Cited by in Crossref: 89] [Cited by in F6Publishing: 70] [Article Influence: 12.7] [Reference Citation Analysis]
13 Schmidt T, Bohné M, Schlüter M, Kitamura M, Wohlmuth P, Schewel D, Schewel J, Schmoeckel M, Kuck KH, Frerker C. The impact of biventricular heart failure on outcomes after transcatheter aortic valve implantation. Clin Res Cardiol 2019;108:741-8. [PMID: 30506481 DOI: 10.1007/s00392-018-1400-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Abraham WT, Psotka MA, Fiuzat M, Filippatos G, Lindenfeld J, Mehran R, Ambardekar AV, Carson PE, Jacob R, Januzzi JL Jr, Konstam MA, Krucoff MW, Lewis EF, Piccini JP, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Zeitler EP, Anker SD, O'Connor CM. Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research Consortium. Eur J Heart Fail 2020;22:2175-86. [PMID: 33017862 DOI: 10.1002/ejhf.2018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Kawai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; for the KCHF Study Investigators. Starting Neurohormonal Antagonists in Patients With Acute Heart Failure With Mid-Range and Preserved Ejection Fraction. Circ J. [DOI: 10.1253/circj.cj-21-0977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ma M, Luo Q, Dong X, Cui S, Hocher B, Zeng S, Liang W, Li Q, Chen X, Chen X, Meng Y, Lu Y, Yang D, Yin L. N-terminal prohormone B-type natriuretic peptide variability acts as a predictor of poor prognosis in patients with cardiorenal syndrome type 2. Bioengineered 2021;12:12407-19. [PMID: 34905428 DOI: 10.1080/21655979.2021.2005219] [Reference Citation Analysis]
17 Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P, Testani JM, Tang WHW, Orso F, Rossignol P, Metra M, Filippatos G, Seferovic PM, Ruschitzka F, Coats AJ. The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:137-155. [PMID: 30600580 DOI: 10.1002/ejhf.1369] [Cited by in Crossref: 218] [Cited by in F6Publishing: 157] [Article Influence: 72.7] [Reference Citation Analysis]
18 Casado Cerrada J, Zabaleta Camino JP, Fontecha Ortega M. Target organ damage in acute heart failure. Rev Clin Esp (Barc) 2016;216:99-105. [PMID: 26460242 DOI: 10.1016/j.rce.2015.08.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Guo Z, Liu J, Sun G, Song F, Lei L, He Y, Liu B, Chen S, Liu Y, Chen J. Post-PCI acute heart failure is an independent predictor of long-term mortality in patients with chronic kidney disease. Int J Cardiol 2020;320:119-23. [PMID: 32464252 DOI: 10.1016/j.ijcard.2020.05.074] [Reference Citation Analysis]
20 Górriz JL, Rico MG, Nuñez J. Tratamiento de la insuficiencia cardiaca en el paciente con insuficiencia renal avanzada. Revista Española de Cardiología Suplementos 2019;18:31-9. [DOI: 10.1016/s1131-3587(20)30007-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Beraldo JI, Benetti A, Borges-Júnior FA, Arruda-Junior DF, Martins FL, Jensen L, Dariolli R, Shimizu MH, Seguro AC, Luchi WM, Girardi ACC. Cardioprotection Conferred by Sitagliptin Is Associated with Reduced Cardiac Angiotensin II/Angiotensin-(1-7) Balance in Experimental Chronic Kidney Disease. Int J Mol Sci 2019;20:E1940. [PMID: 31010001 DOI: 10.3390/ijms20081940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
22 Schmidt T, Frerker C. Treatment Challenges in Patients with Acute Heart Failure and Severe Aortic Valve Stenosis. Curr Cardiol Rep 2019;21:47. [PMID: 31011842 DOI: 10.1007/s11886-019-1135-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Chaudhary K, Petrazzini BO, Narula J, Nadkarni GN, Do R. Prediction of Incident Heart Failure in TTR Val122Ile Carriers One Year Ahead of Diagnosis in a Multiethnic Biobank. Am J Cardiol 2021;142:151-3. [PMID: 33333072 DOI: 10.1016/j.amjcard.2020.12.015] [Reference Citation Analysis]
24 Yagi R, Takei M, Kohsaka S, Shiraishi Y, Ikemura N, Shoji S, Niimi N, Higuchi S, Goda A, Kohno T, Nagatomo Y, Nishihata Y, Sujino Y, Saji M, Ikegami Y, Nakano S, Takahashi T, Fukuda K, Yoshikawa T. Phenomapping in patients experiencing worsening renal function during hospitalization for acute heart failure. ESC Heart Fail 2021;8:5192-203. [PMID: 34545703 DOI: 10.1002/ehf2.13598] [Reference Citation Analysis]
25 Seko Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Ozasa N, Shiba M, Yamamoto E, Yoshikawa Y, Yamashita Y, Kitai T, Taniguchi R, Iguchi M, Nagao K, Jinnai T, Komasa A, Nishikawa R, Kawase Y, Morinaga T, Toyofuku M, Furukawa Y, Ando K, Kadota K, Sato Y, Kuwahara K, Kimura T; KCHF Study Investigators. Newly Diagnosed Infection After Admission for Acute Heart Failure: From the KCHF Registry. J Am Heart Assoc 2021;10:e023256. [PMID: 34730004 DOI: 10.1161/JAHA.121.023256] [Reference Citation Analysis]
26 Nakamura H, Niwano S, Fukaya H, Murakami M, Kishihara J, Satoh A, Yoshizawa T, Oikawa J, Ishizue N, Igarashi T, Fujiishi T, Ako J. Cardiac troponin T as a predictor of cardiac death in patients with left ventricular dysfunction. J Arrhythm 2017;33:463-8. [PMID: 29021851 DOI: 10.1016/j.joa.2017.07.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
27 Thiele K, Rau M, Hartmann NK, Möller M, Möllmann J, Jankowski J, Keszei AP, Böhm M, Floege J, Marx N, Lehrke M. Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure. ESC Heart Fail 2022. [PMID: 35611683 DOI: 10.1002/ehf2.13955] [Reference Citation Analysis]
28 Pérez Calvo JI, Josa Laorden C, Giménez López I. Renal function assessment in heart failure. Rev Clin Esp (Barc) 2017;217:267-88. [PMID: 28258719 DOI: 10.1016/j.rce.2017.01.006] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
29 Farmakis D, Parissis J, Karavidas A, Karvounis C, Triposkiadis F, Filippatos G, Lekakis J, Barbetseas J, Giannadaki M, Kakouros S, Karamitsos T, Kitsiou A, Lampropoulos S, Mazarakis A, Milkas A, Papadopoulos C, Patsilinakos S, Siniorakis E, Sotirellos K, Theodosis-georgilas A, Vlasopoulou N. In-hospital management of acute heart failure: Practical recommendations and future perspectives. International Journal of Cardiology 2015;201:231-6. [DOI: 10.1016/j.ijcard.2015.08.030] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
30 Moreira RI, Cunha PS, Rio P, da Silva MN, Branco LM, Galrinho A, Feliciano J, Soares R, Ferreira RC, Oliveira MM. Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction. J Interv Card Electrophysiol 2018;51:237-44. [PMID: 29460235 DOI: 10.1007/s10840-018-0330-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Brankovic M, Akkerhuis KM, van Boven N, Manintveld O, Germans T, Brugts J, Caliskan K, Umans V, Constantinescu A, Kardys I. Real-Life Use of Neurohormonal Antagonists and Loop Diuretics in Chronic Heart Failure: Analysis of Serial Biomarker Measurements and Clinical Outcome. Clin Pharmacol Ther 2018;104:346-55. [PMID: 29105751 DOI: 10.1002/cpt.931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
32 Abraham WT, Psotka MA, Fiuzat M, Filippatos G, Lindenfeld J, Mehran R, Ambardekar AV, Carson PE, Jacob R, Januzzi JL, Konstam MA, Krucoff MW, Lewis EF, Piccini JP, Solomon SD, Stockbridge N, Teerlink JR, Unger EF, Zeitler EP, Anker SD, O’connor CM. Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium. JACC: Heart Failure 2020;8:961-72. [DOI: 10.1016/j.jchf.2020.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-juanatey JR, Harjola V, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members, Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the spec. Eur J Heart Fail 2016;18:891-975. [DOI: 10.1002/ejhf.592] [Cited by in Crossref: 3626] [Cited by in F6Publishing: 3057] [Article Influence: 604.3] [Reference Citation Analysis]
34 Zhu H, Qian Y. Serum neutrophil gelatinase-associated lipocalin and cystatin C are diagnostic markers of renal dysfunction in older patients with coronary artery disease. J Int Med Res 2018;46:2177-85. [PMID: 29595358 DOI: 10.1177/0300060517748842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
35 Yaku H, Kato T, Morimoto T, Inuzuka Y, Tamaki Y, Ozasa N, Yamamoto E, Yoshikawa Y, Kitai T, Kato M, Ikeda T, Furukawa Y, Nakagawa Y, Sato Y, Kuwahara K, Kimura T. Risk factors and clinical outcomes of functional decline during hospitalisation in very old patients with acute decompensated heart failure: an observational study. BMJ Open 2020;10:e032674. [PMID: 32066601 DOI: 10.1136/bmjopen-2019-032674] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
36 Horiuchi Y, Wettersten N, van Veldhuisen DJ, Mueller C, Filippatos G, Nowak R, Hogan C, Kontos MC, Cannon CM, Müeller GA, Birkhahn R, Taub P, Vilke GM, Barnett O, McDonald K, Mahon N, Nuñez J, Briguori C, Passino C, Duff S, Maisel A, Murray PT. Decongestion, kidney injury and prognosis in patients with acute heart failure. Int J Cardiol 2022:S0167-5273(22)00261-3. [PMID: 35202737 DOI: 10.1016/j.ijcard.2022.02.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]